Gennex Laboratories

GENNEX

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

‌

‌
‌

‌
‌
‌

‌
‌

‌

‌
‌
‌
‌
‌
‌
‌

‌
‌
‌
‌
‌
‌

Gennex Laboratories Stock Price - ₹9.03 | Healthcare | askfuzz

Gennex Laboratories

GENNEX

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

Announcements

Exchange filings, newest first

1 Oct
4 Sept
27 Aug

Documents by quarter

Results, presentation and transcript tracked for every quarter

Quarterly Result Q1 FY2026-27

3 pages

Annual Reports

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

25 pages

Annual Reports 2024-25

153 pages

Annual Reports 2023-24

163 pages

Other Filings

KMP changes, governance and LODR disclosures

DateFilingCategory

1 Oct 2026Gennex Laboratories Ltd AGM voting results for meeting held on 30 Sep 2026Record Date

30 Sept 2026Gennex Laboratories Ltd proceedings of the 41st Annual General Meeting held on 30 Sep 2026Record Date

30 Sept 2026Gennex Laboratories Ltd appoints Mr. Dipankar Dasgupta as Independent Director effective Oct 01, 2026; Mr. Amudala Sreeramulu Nageswar Rao retiresKMP

5 Sept 2026Gennex Laboratories Ltd book closure from 23 Sep 2026 to 30 Sep 2026 for 41st AGMRecord Date

4 Sept 2026Gennex Laboratories Ltd board meeting outcome on 04 Sep 2026 approving AGM schedule and audit reportsRecord Date

30 May 2026Gennex Laboratories Limited submission of Annual Secretarial Compliance Report for FY26 under Regulation 24A scheduled on May 30, 2026Audit Reports

21 Apr 2026Gennex Laboratories Limited EGM notice for appointment of Additional Director Ms. Khushbu Kachhawa under Regulation 47 scheduled on 12 May 2026Record Date